×
About 500 results

ALLMedicine™ Cockayne Syndrome Center

Research & Reviews  183 results

Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
https://clinicaltrials.gov/ct2/show/NCT00001813

Mar 3rd, 2023 - Three rare genetic diseases, xeroderma pigmentosum (XP), Cockayne syndrome (CS), and trichothiodystrophy (TTD) have defective DNA excision repair although only XP has increased cancer susceptibility. We plan to perform careful clinical examination...

The Spectrum of MORC2-Related Disorders: A Potential Link to Cockayne Syndrome.
https://doi.org/10.1016/j.pediatrneurol.2023.01.011
Pediatric Neurology; Stafki SA, Turner J et. al.

Feb 16th, 2023 - Cockayne syndrome (CS) is a DNA repair disorder primarily associated with pathogenic variants in ERCC6 and ERCC8. As in other Mendelian disorders, there are a number of genetically unsolved CS cases. We ascertained five individuals with monoalleli...

A case of Cockayne syndrome with unusually mild clinical manifestations.
https://doi.org/10.1111/1346-8138.16679
The Journal of Dermatology; Tsujimoto M, Nakano E et. al.

Jan 4th, 2023 - We present a mild case of Cockayne syndrome that was referred to us with an extreme sunburn at the age of 3. In early teens, although her cutaneous symptoms alleviated without any medications, she developed tremor and dysarthria. Neurological exam...

Novel Presentation of Hemiplegic Migraine in a Patient With Cockayne Syndrome.
https://doi.org/10.1016/j.pediatrneurol.2022.10.007
Pediatric Neurology; Carroll J, Pabst L et. al.

Nov 27th, 2022 - Cockayne syndrome is a rare DNA repair disorder marked by premature aging, poor growth, and intellectual disability. Neurological complications such as seizures, movement disorder, and stroke have been reported. Hemiplegic migraine has not been re...

Natural History Study for DNA Repair Disorders
https://clinicaltrials.gov/ct2/show/NCT05484570

Nov 8th, 2022 - This will be a single-center, single-arm, non-interventional natural history study to evaluate the longitudinal clinical course, functional outcome measures, and candidate biomarkers for individuals with DNA repair disorders, including Cockayne sy...

see more →

Drugs  9 results see all →

Clinicaltrials.gov  6 results

Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
https://clinicaltrials.gov/ct2/show/NCT00001813

Mar 3rd, 2023 - Three rare genetic diseases, xeroderma pigmentosum (XP), Cockayne syndrome (CS), and trichothiodystrophy (TTD) have defective DNA excision repair although only XP has increased cancer susceptibility. We plan to perform careful clinical examination...

Natural History Study for DNA Repair Disorders
https://clinicaltrials.gov/ct2/show/NCT05484570

Nov 8th, 2022 - This will be a single-center, single-arm, non-interventional natural history study to evaluate the longitudinal clinical course, functional outcome measures, and candidate biomarkers for individuals with DNA repair disorders, including Cockayne sy...

Metabolic Study of Cockayne Syndrome
https://clinicaltrials.gov/ct2/show/NCT03044210

Aug 19th, 2022 - Cockayne syndrome (CS) is related to defective DNA transcription and/or repair and belongs to the family of Nucleotide Excision Repair. It is an autosomal recessive multisystemic disorder characterized by mental retardation, microcephaly, severe g...

Growth Curves in Cockayne Syndrome Type 1 and Type 2
https://clinicaltrials.gov/ct2/show/NCT05090917

Dec 1st, 2021 - Despite the natural progression of Cockayne's syndrome, affected patients also present with variable neurological and gastrointestinal damage (gastroesophageal reflux, recurrent vomiting, swallowing disorders, etc.) with varying repercussions on t...

Pharmacokinetics and Safety Study of Single and Multiple Oral Doses Prodarsan™ in Patients With Cockayne Syndrome
https://clinicaltrials.gov/ct2/show/NCT01142154

Jun 23rd, 2011 - This study is to compare the exposure of orally administered Prodarsan to the intravenous dosed Osmitrol (10% solution) in Cockayne Syndrome (CS) patients. Also the pharmacokinetics of single and multiple orally dosed Prodarsan will be evaluated a...

see more →

News  2 results

NHS England Boss Knighted in New Year Honours
https://www.medscape.com/viewarticle/923186

Dec 28th, 2019 - Simon Stevens, head of NHS England becomes a Sir, leading this year's healthcare field in the 2020 New Year Honours List. The recipients in healthcare are alongside stars of sport, entertainment, public service, politics, charity work, and "the ou...

Pediatric Photosensitivity Disorders
https://www.mdedge.com/dermatology/article/110450/pediatric-photosensitivity-disorders
Swetha N. Pathak, MD, Jacqueline De Luca, MD

Jul 19th, 2016 - Review the PDF of the fact sheet on pediatric photosensitivity disorders with board-relevant, easy-to-review material. This month's fact sheet will review important disorders in the pediatric population where photosensitivity is a major feature Pr.

see more →